Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
August 08 2023 - 9:05AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2023
Commission
File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
10
HaNechoshet Street Tel-Aviv, 6971072, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
EXPLANATORY
NOTE
On
August 8, 2023, Medigus Ltd. issued a press release titled: “Medigus: ParaZero Receives Second Order from One of the World’s
Largest Automotive Manufacturers.” A copy of this press release is furnished herewith as Exhibit 99.1
EXHIBIT
INDEX
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
MEDIGUS LTD. |
|
|
|
Date: August 8, 2023 |
By: |
/s/ Tali Dinar |
|
|
Tali Dinar |
|
|
Chief Financial Officer |
3
Exhibit 99.1
Medigus:
ParaZero Receives Second Order from One of the World’s Largest Automotive Manufacturers
The repeat order is for a custom safety
solution for a Fortune 500 automotive manufacturer’s proprietary drone program.
Tel Aviv, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE)
-- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions,
and innovative internet technologies, today announced that ParaZero Technologies Ltd. (PRZO) (“ParaZero”), an aerospace company
focused on drone safety systems for commercial drones and urban air mobility aircraft, (33.36% owned by Medigus), has received a second
order for its custom drone safety system by one of the world’s largest automotive manufacturers.
The repeat order follows an agreement previously signed with the
automotive manufacturer for the development of a bespoke safety solution for its proprietary drone program.
The automotive manufacturer plans to integrate ParaZero’s SafeAir™
drone safety system into their proprietary aircraft from the design stage, allowing for an optimized and seamless integration. ParaZero
has a proven history of supplying advanced safety solutions for global manufacturers and companies across a myriad of aerial platforms,
including multirotor, single rotor, fixed wing, vertical takeoff and landing (VTOL), manned and unmanned, and urban air mobility aircraft.
About ParaZero Technologies
ParaZero
(https://parazero.com/) is a world-leading developer of autonomous parachute safety systems for commercial drone and urban
air mobility (UAM) aircraft. Started in 2014 by a passionate group of aviation professionals and drone industry veterans, ParaZero designs
smart, autonomous parachute safety systems designed to enable safe flight operations overpopulated areas and beyond-visual-line-of-sight
(BVLOS).
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is
a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and
electric vehicle markets. Medigus’ affiliations in the medical solutions arena consist of ownership in Polyrizon Ltd. The Company’s
affiliates in digital commerce include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle
market, Charging Robotics Ltd. and Revoltz, by way of Fuel Doctor Holdings, Inc., are also part of the Company’s portfolio of technology
solution providers. Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward Looking Statements
This press
release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,”
“plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such
words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Medigus’
current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus
could differ materially from those described in or implied by the statements in this press release. For example, Medigus uses forward
looking statements when describing the potential integration of ParaZero’s solutions in the automotive manufacturer’s proprietary
drone program.
The forward-looking
statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings
with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking
statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and
links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference
into this press release. Medigus is not responsible for the contents of third-party websites.
Company Contact
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Investor Relations Contact:
Michal Efraty
Investor Relations, Israel
+972-(0)52-3044404
michal@efraty.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2024 to May 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From May 2023 to May 2024